Press Releases

Opthea To Present at Upcoming Investor Conferences

May 11, 2022

Read More

Opthea Presentation at The Retina World Congress 2022

May 10, 2022

Read More

Opthea Data for OPT-302 in Combination with Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) Presented at ARVO 2022

May 5, 2022

Read More

Opthea Presenting Clinical Data at ARVO 2022 Annual Meeting

April 29, 2022

Read More

Opthea strengthens its Board of Directors

April 22, 2022

Read More

Opthea To Present at Oppenheimer’s 32nd Annual Healthcare Conference

March 10, 2022

Read More

Opthea Expands Leadership Team with the Appointment of Joel Naor, M.D., M.Sc., MBA as Chief Medical Officer

March 2, 2022

Read More

Opthea Half Year Report and Accounts

February 28, 2022

Read More

Opthea Data for OPT-302 in Patients with Polypoidal Choroidal Vasculopathy (PCV) Presented at Angiogenesis 2022

February 14, 2022

Read More

Angiogenesis 2022 -Prof Cheung presentation of PCV data

February 13, 2022

Read More